Article
TIGIT signalling pathway negatively regulates CD4+ T-cell responses in systemic lupus erythematosus.
Immunology - 1 Jul 2017
Mao Lie, Hou Hongyan, Wu Shiji, Zhou Yu, Wang Juan, Yu Jing, Wu Xiaohui, Lu Yanfang, Mao Liyan, Bosco Munyemana Jean, Wang Feng, Sun Ziyong
Abstract excerpt
B-lymphocyte hyperactivity in systemic lupus erythematosus (SLE) is T-cell-dependent, and CD4+ T-cell activation is essential to SLE pathogenesis. However, the mechanism of the deregulation of CD4+ T cells in SLE is largely unknown. T-cell immunoglobulin and ITIM domain (TIGIT) is a new inhibitory receptor preferentially expressed on activated CD4+ T cells. Here, we address the role of TIGIT in the pathogenesis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
